SHANDONG BOAN BIOTECH.H 1 Financial Flexibility Index
SHANDONG BOAN BIOTECH.H 1 financial flexibility index. SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Financial Flexibility Index of 0.24x as of December 2025. Free cash flow of €338.94 Million (operating CF €64.89 Million minus capex €274.05 Million) represents 0% of total liabilities (€1.39 Billion). See SHANDONG BOAN BIOTECH.H 1 (UJ9) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SHANDONG BOAN BIOTECH.H 1 (2021–2025)
Financial flexibility index of SHANDONG BOAN BIOTECH.H 1 from 2021 to 2025. Historical Financial Flexibility Index trend for SHANDONG BOAN BIOTECH.H 1 across 5 annual periods. Check UJ9 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
SHANDONG BOAN BIOTECH.H 1 Financial Flexibility Index by Year (2021–2025)
SHANDONG BOAN BIOTECH.H 1 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for SHANDONG BOAN BIOTECH.H 1. For the full cash flow conversion analysis, see SHANDONG BOAN BIOTECH.H 1 (UJ9) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | €338.94 Million | €64.89 Million | €1.39 Billion | ▲ +20.5% |
| 2024 | 0.20x | €244.97 Million | €-117.94 Million | €1.21 Billion | ▼ -26.3% |
| 2023 | 0.28x | €276.19 Million | €-18.57 Million | €1.00 Billion | ▲ +4659.1% |
| 2022 | 0.01x | €4.54 Million | €-201.84 Million | €784.18 Million | ▼ -96.6% |
| 2021 | 0.17x | €94.97 Million | €-246.28 Million | €554.92 Million | — |